Structure via PubChem · Public domain (PubChem)
ibopamine
Ibopamine is a sympathomimetic drug, designed as a prodrug of epinine (deoxyepinephrine or N-methyldopamine), used in ophthalmology. It induces mydriasis. It also has been investigated for use in the treatment of congestive heart failure.
Chemical data
- Formula
- C17H25NO4
- Molecular weight
- 307.4 g/mol
- IUPAC name
- [4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- cardiovascular disease
via ChEMBL · EBI
Research
359 papers- Ibopamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in congestive heart failure.Drugs & aging · 1993
- Clinical pharmacology of ibopamine.The American journal of medicine · 1991
~2 min read
Article
6 sectionsContents
- Pharmacokinetics
- Pharmacodynamics
- Toxicology
- Clinical Use
- See also
- References
Ibopamine is a sympathomimetic drug, designed as a prodrug of epinine (deoxyepinephrine or N-methyldopamine), used in ophthalmology. It induces mydriasis. It also has been investigated for use in the treatment of congestive heart failure.
It acts on D1 and α-adrenergic receptors as an agonist.
Connections
Categories
Alpha1-adrenergic agonistsAlpha2-adrenergic agonistsBeta-adrenergic agonistsChemical pages without DrugBank identifierD1 receptor agonistsD2 receptor agonistsDopamine agonistsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs with no legal statusECHA InfoCard ID from WikidataIsobutyrate esters